LE MOLI, ROSARIO
 Distribuzione geografica
Continente #
NA - Nord America 1.727
AS - Asia 1.032
EU - Europa 516
SA - Sud America 326
AF - Africa 27
Totale 3.628
Nazione #
US - Stati Uniti d'America 1.671
SG - Singapore 396
BR - Brasile 272
HK - Hong Kong 190
IT - Italia 169
CN - Cina 140
IE - Irlanda 115
BD - Bangladesh 111
VN - Vietnam 82
DE - Germania 50
FR - Francia 45
GB - Regno Unito 33
AR - Argentina 22
CA - Canada 22
IN - India 21
MX - Messico 20
PL - Polonia 20
NL - Olanda 18
TR - Turchia 16
EC - Ecuador 12
ID - Indonesia 12
IQ - Iraq 11
MA - Marocco 10
FI - Finlandia 9
ES - Italia 8
JP - Giappone 8
SE - Svezia 8
ZA - Sudafrica 7
AT - Austria 6
CO - Colombia 6
MY - Malesia 6
UZ - Uzbekistan 6
NP - Nepal 5
RU - Federazione Russa 5
SA - Arabia Saudita 5
UA - Ucraina 5
CL - Cile 4
HN - Honduras 4
LT - Lituania 4
PE - Perù 4
PH - Filippine 4
PT - Portogallo 4
EE - Estonia 3
JO - Giordania 3
PK - Pakistan 3
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
CH - Svizzera 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
GA - Gabon 2
GR - Grecia 2
JM - Giamaica 2
KG - Kirghizistan 2
PS - Palestinian Territory 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
KR - Corea 1
LV - Lettonia 1
NO - Norvegia 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
Totale 3.628
Città #
Dallas 599
Singapore 226
San Jose 208
Hong Kong 189
Ashburn 172
Dublin 113
The Dalles 78
Beijing 68
Santa Clara 68
Chicago 62
Boardman 57
New York 38
Ho Chi Minh City 31
Los Angeles 25
Assago 22
São Paulo 19
Hanoi 18
Catania 17
Warsaw 15
Council Bluffs 14
Hillsboro 14
Mexico City 14
Naples 13
Düsseldorf 11
Milan 10
Munich 10
Rio de Janeiro 10
Frankfurt am Main 9
Helsinki 9
Istanbul 9
Nuremberg 9
Reston 8
Rome 8
Tokyo 8
Belo Horizonte 7
London 7
Baghdad 6
Brooklyn 6
Buffalo 6
Guarulhos 6
Orem 6
Salvador 6
Seattle 6
Atlanta 5
Brasília 5
Casablanca 5
Lauterbourg 5
Palermo 5
Paris 5
Phoenix 5
Porto Alegre 5
Tashkent 5
Toronto 5
Chennai 4
Johannesburg 4
Manchester 4
Montreal 4
Mumbai 4
Ottawa 4
Quito 4
Ribeirão Preto 4
San Francisco 4
Stockholm 4
Wroclaw 4
Ankara 3
Boston 3
Bắc Ninh 3
Campinas 3
Charlotte 3
Curitiba 3
Da Nang 3
Denver 3
Guayaquil 3
Hải Dương 3
Imperatriz 3
Itaquaquecetuba 3
Lima 3
Limburg an der Lahn 3
Mascalucia 3
Messina 3
New Delhi 3
Pisa 3
Poplar 3
Porto 3
Portsmouth 3
Putian 3
Riyadh 3
Sobral 3
Tallinn 3
Amman 2
Angeles City 2
Asunción 2
Baku 2
Balneário Camboriú 2
Barbacena 2
Bari 2
Bauru 2
Bishkek 2
Bismarck 2
Biên Hòa 2
Totale 2.428
Nome #
Clinical management of indeterminate thyroid nodules needs to be revisited. New evidence for a personalized approach to the problem 124
A marker of inflammatory state and the clinical outcome of active go to parenteral glucocorticoids 89
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy 86
Correlations Between Novel Adiposity Indices and Electrocardiographic Evidence of Left Ventricular Hypertrophy in Individuals with Arterial Hypertension 85
Very low serum IGF-1 levels are associated with vertebral fractures in adult males with beta-thalassemia major 85
A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy 84
Determinants of clinical outcome in patients with moderate/severe Graves' orbitopathy undergoing treatment with parenteral glucocorticoids: a retrospective study 81
Influence of Mediterranean Diet on Sexual Function in People with Metabolic Syndrome: A Narrative Review 78
Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism 78
Consider or not consider: the unsolved question on the use of radioactive iodine for differentiated thyroid cancer with low to intermediate risk of recurrence 77
Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling 77
Early Massive Fibrosis of a Single Extraocular Muscle Causing Severe Unilateral Euthyroid Graves’ Ophthalmopathy in a Patient with Hypercholesterolemia Who Smokes 75
Effect of octreotide on blood glucose and counterregulatory hormones in insulin-dependent diabetic patients: The role of dose and route of administration 74
Early detection of suspicious lymph nodes in differentiated thyroid cancer 74
Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management 73
Role of selenium and myo-inositol supplementation on autoimmune thyroiditis progression 71
Orbital metastasis from thyroid cancer: a case report and review of the literature 70
Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis 70
A Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma: Clinical and Pathologic Features and Outcomes of 34 Consecutive Cases 69
Determinants of longterm outcome of radioiodine therapy of sporadic non- toxic goitre 68
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? 68
The automated correction index (ACI), a novel report-derived metric correlated to glucose control and variability in patients with type 1 diabetes on advanced hybrid closed loop therapy 67
Cholesterol and Graves’ Orbitopathy (GO): ‘A new decision-making algorithm based on baseline low density lipoprotein cholesterol (LDLc) and early GO clinical response to parenteral corticosteroids’ 67
A novel methodology for epidemic risk assessment of COVID-19 outbreak 66
Determinants of Liver Damage Associated with Intravenous Methylprednisolone Pulse Therapy in Graves' Ophthalmopathy 65
The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes 65
Papillary thyroid carcinoma: ≤ 10 mm does not always mean pN0. A multicentric real-world study 59
Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution 58
Recent insights into the pathogenesis of autoimmune hypophysitis 58
Lymph Node Ratio as a Predictive Factor of Persistent/Recurrent Disease in Patients With Medullary Thyroid Cancer: A Single-Center Retrospective Study 56
Integrated insulin pump therapy with continuous glucose monitoring for improved adherence: technology update 56
Mediterranean diet, selenium and Graves’ ophthalmopathy: a prospective, randomized, single-center study 55
Establishment of reference values for endocrine tests II: Hyperprolactinemia 55
Effect of octreotide on blood glucose and counterregulatory hormones in insulin-dependent diabetic patients: the role of dose and route of administration 55
Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves’ Ophthalmopathy to Parenteral Corticosteroids 53
Effect of octreotide on growth hormone, IGF-I, IGFBP-3, glucagon, cortisol and epinephrine response to insulin-induced hypoglycaemia in insulin-dependent diabetic patients 52
Diabetic neuropathy: Prevalence, concordance between clinical and electrophysiological testing and impact of risk factors 52
Type 2 diabetic patients with Graves' disease have more frequent and severe Graves' orbitopathy 51
Effects of Dietary Habits on Markers of Oxidative Stress in Subjects with Hashimoto’s Thyroiditis: Comparison Between the Mediterranean Diet and a Gluten-Free Diet 50
Effect of octreotide on blood glucose levels in poorly compensated insulin-dependent diabetics on insulin treatment|Effetti dell'octreotide sui livelli glicemici in diabetici insulino-dipendenti mal compensati con trattamento insulinico 50
The monocyte/HDLc ratio and LDLc are two independent predictors of the response of Graves’ ophthalmopathy patients to parenteral glucocorticoids 49
Different effects of octreotide by continuous night infusion at increasing rate or by evening injections at different times on morning hyperglycemia and growth hormone levels in insulin-dependent diabetic patients 49
Postoperative basal serum thyroglobulin and need for radioiodine in patients with low to intermediate-risk papillary thyroid cancer 48
Graves’ Orbitopathy: Extraocular Muscle/Total Orbit Area Ratio is Positively Related to the Clinical Activity Score 47
Severe Graves' Ophthalmopathy After Percutaneous Ethanol Injection in a Nontoxic Thyroid Nodule 47
TKIS for advanced thyroid cancer increase tsh levels in thyroidectomized patients: A meta-analysis 47
Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients 46
Efficacy of Botulinum Toxin A for Treating Cramps in Diabetic Neuropathy 46
The contemporary assumption of methimazole and acetominophen caused drug-induced liver injury in a female patient with Graves' disease and ophthalmopathy: A case report 46
Long-term octreotide treatment reduced hyperinsulinemia, excess body weight and skin lesions in severe obesity with acanthosis nigricans 46
Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients 44
Long-term octreotide treatment reduced hyperinsulinemia, excess body weight and skin lesions in severe obesity with acanthosis nigricans 44
Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function 43
Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study 42
Mediterranean diet adherence and tirzepatide: real-world evidence on adiposity indices and insulin resistance beyond weight loss 42
Insulin Analogs and Cancer 42
Lack of pharmacological effect of subcutaneous octreotide in an insulin-dependent diabetic patient: Reversal after mixing with aprotinin 39
Low-intermediate risk thyroid cancer: no benefit of postsurgical iodine? 38
Temporal trends in the clinical presentation of graves' ophthalmopathy: a single - centre retrospective study 38
Rebound effect in hypothalamic-pituitary thyreotropic activity: a new model to better understand hypothyroidism and hormonal replacement therapies 37
Evaluation of endocrine tests. A: The TRH test in patients with hyperprolactinaemia 36
Temporal trends in the clinical presentation of Graves’ orbitopathy: a single–center retrospective study 34
Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review 31
Minimal or Absent Tumor Desmoplasia Predicts Lower Recurrence Risk in Papillary Thyroid Carcinoma 24
Novel adiposity indices and their role in identifying left ventricular hypertrophy among hypertensive individuals undergoing echocardiography 19
Totale 3.770
Categoria #
all - tutte 17.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229 0 0 0 0 6 0 0 3 0 0 0 0
2022/20236 2 0 0 0 0 1 0 0 0 2 1 0
2023/202412 0 1 0 0 1 0 3 1 0 0 4 2
2024/20251.205 98 46 69 31 128 230 103 58 110 123 116 93
2025/20262.538 143 423 416 225 83 82 243 225 174 192 262 70
Totale 3.770